Iovance Biotherapeutics, Inc.
US ˙ NasdaqGM ˙ US4622601007

SecurityIOVA / Iovance Biotherapeutics, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership471,299 shares
Latest Disclosed Value $ 810,634
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series ownership in IOVA / Iovance Biotherapeutics, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 471,299 shares of Iovance Biotherapeutics, Inc. (US:IOVA) valued at $810,634 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 471,299 shares of Iovance Biotherapeutics, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $1,993,595 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Iovance Biotherapeutics EC US4622601007 471,299 0 0.00 811 -48.37 0.0182
2025-05-28 2025-03-31 NP Iovance Biotherapeutics EC US4622601007 471,299 8,264 1.78 1,569 -54.20 0.0376
2025-02-25 2024-12-31 NP Iovance Biotherapeutics EC US4622601007 463,035 -33,461 -6.74 3,426 -26.51 0.0748
2024-11-26 2024-09-30 NP Iovance Biotherapeutics EC US4622601007 496,496 44,364 9.81 4,662 28.57 0.0882
2024-08-26 2024-06-30 NP Iovance Biotherapeutics EC US4622601007 452,132 36,209 8.71 3,626 -41.17 0.0738
2024-05-28 2024-03-31 NP Iovance Biotherapeutics EC US4622601007 415,923 -1,821 -0.44 6,164 81.48 0.1286
2024-02-26 2023-12-31 NP Iovance Biotherapeutics EC US4622601007 417,744 28,802 7.41 3,396 91.97 0.0725
2023-11-28 2023-09-30 NP Iovance Biotherapeutics EC US4622601007 388,942 29,091 8.08 1,770 -30.16 0.0462
2023-08-25 2023-06-30 NP Iovance Biotherapeutics EC US4622601007 359,851 118,813 49.29 2,533 72.08 0.0601
2023-05-26 2023-03-31 NP Iovance Biotherapeutics EC US4622601007 241,038 0 0.00 1,473 -4.42 0.0392
2023-02-24 2022-12-31 NP Iovance Biotherapeutics EC US4622601007 241,038 -7,013 -2.83 1,540 -35.19 0.0424
2022-11-25 2022-09-30 NP Iovance Biotherapeutics EC US4622601007 248,051 15,115 6.49 2,376 -7.58 0.0681
2022-08-25 2022-06-30 NP Iovance Biotherapeutics EC US4622601007 232,936 232,936 2,572 0.0710
2020-08-27 2020-06-30 NP Iovance Biotherapeutics EC US4622601007 0 -193,070 -100.00 0 -100.00
2020-06-01 2020-03-31 NP Iovance Biotherapeutics EC US4622601007 193,070 10,585 5.80 5,780 14.41 0.2363
2020-02-27 2019-12-31 NP Iovance Biotherapeutics EC 462260100 182,485 6,910 3.94 5,051 58.09 0.1519
2019-11-27 2019-09-30 NP Iovance Biotherapeutics EC US4622601007 175,575 175,575 3,195 0.1056
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.